Constanze Hilgendorf
- Oncology top 2%
- Molecular Biology top 10%
- Pediatrics, Perinatology and Child Health top 2%
- Pharmacology top 0.5%
- Pharmaceutical Science top 1%
- Co-authors
- Anna‐Lena UngellPer ArturssonAnnick SeithelJohan KarlssonGustav AhlinPeter LangguthHildegard Spahn‐LangguthC G Regårdh
- Topics
- Drug Transport and Resistance Mechanisms (27 papers)Pharmacogenetics and Drug Metabolism (11 papers)Pharmacological Effects and Toxicity Studies (8 papers)
- Journals
- Scientific ReportsJournal of Medicinal ChemistryJournal of Pharmacology and Experimental Therapeutics
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Constanze Hilgendorf
39 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 111
- Oncology 1.3k
- Molecular Biology 800
- Pediatrics, Perinatology and Child Health 550
- Pharmacology 497
- Pharmaceutical Science 361
Countries citing papers authored by Constanze Hilgendorf
This map shows the geographic impact of Constanze Hilgendorf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constanze Hilgendorf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constanze Hilgendorf more than expected).
Fields of papers citing papers by Constanze Hilgendorf
This network shows the impact of papers produced by Constanze Hilgendorf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constanze Hilgendorf. The network helps show where Constanze Hilgendorf may publish in the future.
Co-authorship network of co-authors of Constanze Hilgendorf
This figure shows the co-authorship network connecting the top 25 collaborators of Constanze Hilgendorf. A scholar is included among the top collaborators of Constanze Hilgendorf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constanze Hilgendorf. Constanze Hilgendorf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 15 | |
| 4 | 3 | |
| 5 | 11 | |
| 6 | 10 | |
| 7 | 24 | |
| 8 | 94 | |
| 9 | 160 | |
| 10 | 26 | |
| 11 | 52 | |
| 12 | 9 | |
| 13 | 31 | |
| 14 | 15 | |
| 15 | 30 | |
| 16 | 112 | |
| 17 | 457 | |
| 18 | 71 | |
| 19 | 366 | |
| 20 | 179 |
About Constanze Hilgendorf
Constanze Hilgendorf is a scholar working on Pharmacology, Oncology and Pharmaceutical Science, having authored 40 papers that have together received 2.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (27 papers), Pharmacogenetics and Drug Metabolism (11 papers) and Pharmacological Effects and Toxicity Studies (8 papers). The work is most often cited by research in Pharmaceutical Science (361 citations), Pharmacology (497 citations) and Oncology (1.3k citations). Constanze Hilgendorf has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Anna‐Lena Ungell, Per Artursson, Annick Seithel, Johan Karlsson, Gustav Ahlin, Peter Langguth, Hildegard Spahn‐Langguth, C G Regårdh, Elke Lipka and Gordon L. Amidon. Their work appears in journals such as Scientific Reports, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.